InvestmentInvested in Carecubes' $6.5M Series A for deployable infectious disease isolation units.CareCubesCareCubesLifeforce Capitalprnewswire.comMAR 19, 2026MAR 19, 2026
InvestmentParticipated in Character Biosciences' $93M Series B for precision eye disease therapies.Character BiosciencesCharacter BiosciencesLifeforce Capital